Document:

DC7587.pdf -- Converted by SEC Publisher 4.2, created by BCL Technologies Inc., for SEC Filing

	
Exhibit 10.1

	
SUBSCRIPTION AGREEMENT

THE SECURITIES OFFERED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY JURISDICTION. THE SECURITIES MAY NOT BE SOLD, OFFERED FOR SALE, TRANSFERRED OR ASSIGNED UNLESS
(A) THEY ARE REGISTERED PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND SUCH LAWS OF ANY JURISDICTION AS MAY BE APPLICABLE, OR (B) SOLD IN RELIANCE ON AN OPINION OF COUNSEL
SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED OR (C) SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT.

	
Encorium Group, Inc.

400 Berwyn Park

899 Cassatt Road, Suite 115,

Berwyn, Pennsylvania

Attention: Kai Lindevall, Chairman

Re: Subscription for Shares of Common Stock

	
Ladies and Gentlemen:

Subject to the terms and conditions herein set forth, I hereby agree to purchase from Encorium Group, Inc. (the “Company”), and upon the Company’s acceptance of this subscription (the “Subscription
Agreement”) the Company agrees to issue and sell to me, (i) the number of shares (the “Shares”) of Common Stock, par value $.001 per share, of the Company (the “Common Stock”) indicated on the signature page hereof. The
aggregate purchase price for the Shares is indicated on the signature page hereof (the “Subscription Amount”). I acknowledge that my subscription is irrevocable. Prior to acceptance hereof by the Company, I understand that the Subscription
Amount will be held in a separate bank account in the Wayne, Pennsylvania area (the “Escrow Account”). At such time as the Company has accepted the subscription the Subscription Amount will be disbursed to the Company from the Escrow
Account. If the Company does not accept my subscription by October 30, 2009 the Subscription Amount will be promptly returned to me without interest.

PHILADELPHIA\5319867\1 257335.000

	
(a) 
		
 		
Accredited Investor Status. I acknowledge that the following apply to me: 
	
	
 
		
 		
[ ] (A) 
		
 		
I am a natural person whose individual net worth, or joint net 
	

worth with my spouse, at the time of my purchase exceeds $1,000,000.

[ ] (B) I am a natural person who had an individual income in excess of

$200,000 in each of the two most recent years and who reasonably expects an income in excess of such amount in the current year.

[ ] (C) I am a natural person who had joint income with my spouse in

excess of $300,000 in each of the two most recent years and who reasonably expects an income in excess of such amount in the current year.

     (b) Transfer Restrictions; Investment Representations. I understand that the sale, hypothecation, transfer, assignment and any other
disposition of the Shares is restricted and that the Shares have not been registered under the Securities Act of 1933 (the “Act”) or the laws of any other jurisdiction. The Shares cannot be sold or transferred by me unless they are (i)
subsequently registered under applicable law, (ii) sold in accordance with an opinion of counsel acceptable to the Company that the Shares may be sold pursuant to an exemption from registration, or (iii) sold pursuant to Rule 144 or Rule 144A under
the Act; Accordingly, understand that I may not be able to sell any Shares and I must bear the economic risk of my investment for an indefinite period of time;

     (c) Risks. I acknowledge that there are various substantial risks attendant to the Company's business and the ownership of the Shares. I have
considered the risks associated with such an investment, including the risks described under the heading "Risk Factors"  in the Company’s Annual Report on Form 10-K for the year ending
on December 31, 2008 and the Company’s Quarterly Report on Form 10-Q for the Quarterly Period ended June 30, 2009. No representations or warranties have been made concerning the success of the business or the potential profit on an investment
in the Company.

     (d) Warrant Exchange Agreements. I acknowledge that prior to the execution hereof the Company is entering into (i) a warrant exchange
agreement with Capital Ventures International, in the form attached hereto as Exhibit A and (ii) a warrant exchange agreement with Enable Growth Partners, LP, in the form attached hereto as Exhibit B.

	
(e)      		
Representations and Warranties.	
	 
	
(i)      		
The Company represents and warrants that:	
	 

	
A.      		
The Company is a corporation duly organized and validly subsisting under the laws of the State of Delaware;	
	 
	
B.      		
As of the date hereof, the authorized capital stock of the Company consists of 35,000,000 shares of Common Stock, of which 26,325,383 shares of Common Stock will be issued and outstanding immediately following the
Closing:	
	 

	
2

PHILADELPHIA\5319867\1 257335.000

	
C.      		
Upon payment of the purchase price set forth herein, the Shares to be issued to me shall be validly issued, fully paid and non-assessable; and	
	 
	
D.      		
The Company has all requisite corporate power and authority to execute, deliver and consummate the transactions contemplated by this Subscription Agreement.	
	 
	 	
This Subscription Agreement has been duly authorized by all necessary action on the party of the Company; no other act or proceeding on the part of the Company is necessary to authorize this Subscription Agreement or the
transactions contemplated hereby. This Subscription Agreement constitutes the legal, valid and binding obligation of the Company, enforceable in accordance with the terms hereof, except as enforceability may be limited by applicable bankruptcy,
insolvency or similar laws affecting the enforcement of creditors’ rights generally.	
	 
	
E.      		
Neither the execution and delivery by the Company of this Subscription Agreement, nor the consummation by the Company of the transactions contemplated hereby, will (A) violate any provision of the Delaware General Corporation Law,
the Company’s Certificate of Incorporation or Bylaws or (B) violate, conflict with, or constitute a default (or an event or condition which, with notice or lapse of time or both, would constitute a default) under, or result in the termination
of, or accelerate the performance required by, or cause the acceleration of the maturity of any liability or obligation pursuant to, or result in the creation or imposition of any security interest, lien, charge or other encumbrance upon any of the
property or assets of the Company under any note, bond, mortgage, indenture, deed of trust, license, lease, contract, commitment, understanding, arrangement, agreement or restriction of any kind or character to which the Company is a party or by
which it may be bound or affected or to which any of its property or assets may be subject, or violate any statute or law or any judgment, decree, order, writ, injunction, regulation or rule of any court or governmental authority.	
	 

	 	
(ii) I represent and warrant that:

	
A.      		
My knowledge and experience in financial and business matters are such that I am capable of evaluating the merits and risks of my purchase of the Shares contemplated by this Subscription Agreement;	
	 
	
B.      		
I have been given the opportunity to ask questions of, and receive answers from, directors, officers and other representatives of the Company concerning the business, financial condition and affairs of the Company, and the terms
and conditions of this Subscription Agreement, and have received, to my satisfaction, all such other information and documents as I have requested in order to evaluate an investment in the Company;	
	 
	
C.      		
I have adequate means of providing for my current needs and possible personal contingencies and have no need for liquidity in my investment in the Company. I am able to bear the economic risk of investment in the Company, and can
afford a	
	 

	
3

PHILADELPHIA\5319867\1 257335.000

	 	
complete loss of my investment without adversely affecting my standard of living;	
	 
	
D.      		
I recognize that this Subscription Agreement and the other information furnished by the Company do not constitute investment, accounting, legal or tax advice. I am relying on my own professional advisers for such advice and have
reviewed the merits of an investment in the Securities with my tax and legal counsel and with an investment adviser to the extent I have deemed advisable. I understand that the law firms of Cozen O’Connor represent the interests of the Company
and have not been retained to render any legal, tax, investment or other advice to the undersigned;	
	 
	
E.      		
I represent that the Shares I will receive pursuant to this Subscription Agreement are being acquired by me in good faith solely for my account, for investment purposes only, and are not being purchased with a view to or for the
resale or distribution thereof, or for the account, in whole or in part, of others, and further, I will hold such Shares as an investment; and	
	 
	
F.      		
My authorization, execution, delivery, and performance of this Subscription Agreement does not conflict with any other agreement or arrangement to which I am a party or by which I am bound. This Subscription Agreement has been
duly executed and delivered by me. This Subscription Agreement constitutes the legal, valid and binding obligation of the undersigned, enforceable in accordance with the terms hereof, except as enforceability may be limited by applicable bankruptcy,
insolvency or similar laws affecting the enforcement of creditors’ rights generally.	
	 
	
G.      		
I currently am the beneficial holder of 1,230,177 shares of Common Stock of the Company.	
	 

     (f) Indemnification and Hold Harmless. If I breach any agreement, representation or warranty I have made herein, I agree to indemnify and
hold harmless the Company against any claim, liability, loss, damage or expense (including reasonable attorneys’ fees and other costs of investigating and litigating claims) caused by my breach.

     (g) Binding Nature of Agreement; No Assignment. This Subscription Agreement shall be binding upon and inure to the benefit of the parties
hereto and their respective heirs, personal representatives, successors and assigns, except that no party may assign or transfer its rights or obligations under this Subscription Agreement without the prior written consent of the other parties
hereto.

     (h) Revocation. Subscriber hereby acknowledges and agrees that Subscriber is not entitled to cancel, terminate or revoke this subscription or
any agreement hereunder and that this subscription and all such agreements shall survive the death, disability or incapacity of Subscriber.

	
4

PHILADELPHIA\5319867\1 257335.000

     (i) Governing Law. This Subscription Agreement shall be construed in accordance with and governed by the laws of the State of Pennsylvania
applicable to agreements made and to be performed wholly within that jurisdiction.

     (j) Counterparts. This Subscription Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to
be an original and all of which shall constitute the same instrument.

     (k) Entire Agreement. This Subscription Agreement contains the entire agreement and understanding of the parties with respect to the subject
matter hereof. Any and all prior and contemporaneous discussions, negotiations, commitments, understandings, representations and warranties relating to the transactions contemplated herein are hereby superseded in all respects by this Subscription
Agreement.

	
5

PHILADELPHIA\5319867\1 257335.000

	
SUBSCRIPTION AGREEMENT

SIGNATURE PAGE

Please complete two copies of this Signature Page and return both copies to the Company as follows: Encorium Group, Inc. Encorium Group, Inc., Keilaranta, 10 Finland, FI-02150 Espoo, Attention: Kai Lindevall (Facsimile: +358 20
751 8250).

	
Ilari Koskelo 
		
 		
358-405108408 
	
	
		
		

	
	
Purchaser’s Name - Please Print 
		
 		
Telephone Number 
	
	
 
	
	
250659-037C 
		
 		
 
	
	

		
		
	
	
Social Security/Tax I.D. Number 
		
 		
 
	

Peräsintie 11, 00980 Helsinki, Finland

Notice Address (including City, State and Zip Code)

	
/s/ Ilari Koskelo 
		
 		
October 14, 2009 
	
	

		
		

	
	
Signature 
		
 		
Date 
	
	
Shares of Common Stock to be Purchased: 
		
 		
                                              3,937,500 Shares 
	
	
Aggregate Purchase Price: 
		
 		
                                          $1,575,000 
	

	
AGREED TO AND ACCEPTED:

	
By: /s/ Philip L. Calamia 
		
 		
 
	
	
ENCORIUM GROUP, INC. 
		
 		
Date: October 16, 2009 
	

	
6

PHILADELPHIA\5319867\1 257335.000DC7588.pdf -- Converted by SEC Publisher 4.2, created by BCL Technologies Inc., for SEC Filing

Exhibit 10.2

WARRANT EXCHANGE AGREEMENT

This Warrant Exchange Agreement (this “Agreement”) is dated as of October ___ 2009,

among Encorium Group, Inc. a Delaware corporation (the “Company”), and 
______________________________
(the “Holder”)

     WHEREAS, the Holder is the holder of that certain Warrant to purchase 437,063 shares of Common Stock of the Company, dated as May 9, 2007 (the “Original
Warrant”); and

      WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Sections 3(a)(9) and 4(2) of the Securities Act of 1933, as amended (the
“1933 Act”), the Company desires to exchange with the Holder, and the Holder, desires to exchange with the Company, the Original Warrant for shares of Common Stock and a new Warrant, as more fully described in this Agreement.

     NOW, THEREFORE, in consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which
are hereby acknowledged, the Company and the Holder agree as follows (with capitalized terms used here in and not otherwise defined having the meanings set forth in the Original Warrant):

     1. Exchange of the Original Warrant. On the terms and subject to the conditions set forth herein, as of the date hereof (the
“Closing Date”), the Holder hereby sells, assigns, delivers and transfers to the Company all of its right, title and interest in and to the Original Warrant in exchange for (a) 
_______________
shares of the Company’s freely
tradable Common Stock (the “Exchange Shares”) and (b) a new Warrant in the form attached hereto as Exhibit A (the “Exchange Warrant”), with an Exercise Price of $0.40
per share.

     2. Deliveries. On the date hereof, the Company shall deliver to the Holder (a) the Exchange Shares by electronic delivery at the applicable balance account at the
Depositary Trust Company (“DTC”) in accordance with the instructions set forth on Schedule A hereto and (b) a duly executed copy of the Exchange Warrant.

	
3.      		
Representations and Warranties	
	 
	 	
(a) Mutual Representations and Warranties. Each party hereto hereby makes	
	 

the following representations and warranties to the other party hereto: 

     (i) It is duly organized and validly existing, in good standing under the laws of its jurisdiction of incorporation or organization.

     (ii) (A) It has full power and authority to enter into this Agreement and to consummate the transactions contemplated hereby, and (B) the person who has executed this Agreement on its behalf is duly
authorized to do so and thereby bind the party on whose behalf he or she is purporting to act.

PHILADELPHIA\5320727\5 254797.000

     (iii) This Agreement is its valid and binding agreement, enforceable against it in accordance with its terms.

     (iv) Neither the execution and delivery of this Agreement, nor the consummation of the transactions contemplated hereby, will violate, result in a breach of any of the terms or provisions of,
constitute a default (or any event that, with the giving of notice or the passage of time or both would constitute a default) under, accelerate any obligations under, or conflict with, (i) its charter, articles or certificate of incorporation,
partnership agreement or bylaws (or other organizational documents), if applicable, or any agreement, indenture or other instrument to which it is a party or by which it or its properties are bound, (ii) any judgment, decree, order or award or any
court, governmental body or arbitrator to which it is subject or (iii) any law, rule or regulation applicable to it.

     (b) Representations, Warranties and Covenants of the Company.  The Company hereby represents, warrants and covenants to the Holder
that:

     (i) The Exchange Shares and the Exchange Warrant are duly authorized and, upon issuance in accordance with the terms hereof, shall be validly issued and free from all taxes, liens and charges with
respect to the issue thereof and the Exchange Shares shall be fully paid and nonassessable with the Holder being entitled to all rights accorded to a holder of Common Stock. As of the Closing Date, the Company shall have duly authorized and reserved
for issuance a number of shares of Common Stock which equals the number of Warrant Shares issuable upon exercise of the Exchange Warrant (the “Warrant Shares”). Upon exercise in accordance with the Warrants, the Warrant Shares will be
validly issued, fully paid and nonassessable and free from all taxes, liens and charges with respect to the issue thereof, with the holders being entitled to all rights accorded to a holder of Common Stock.  The offer and issuance by the Company of
the Exchange Shares and Exchange Warrant is exempt from registration under the 1933 Act.

     (ii) The Company is not required to obtain any consent, authorization or order of, or make any filing or registration with, any court, governmental agency or any regulatory or self-regulatory agency
or any other person, including, without limitation, any other security holders of the Company, in order for it to execute, deliver or perform any of its obligations under or contemplated by this Agreement.  All consents, authorizations, orders,
filings and registrations which the Company is required to obtain pursuant to the preceding sentence have been obtained or effected on or prior to the date hereof. Except with respect to its share price and stockholders equity and except as has been
disclosed in writing to the Holder, the Company is not in violation of the listing requirements of the Principal Market and has no knowledge of any facts that would reasonably lead to delisting or suspension of the Common Stock in the foreseeable
future.

     (iii) The exchange of the Original Warrant for the Exchange Shares and Exchange Warrant is being consummated pursuant to Sections 3(a)(9) and Rule 149 of the Securities Act. The Company has not
engaged in any general solicitation or engaged or agreed to compensate any broker or agent in connection with the transactions contemplated by this

	
2

PHILADELPHIA\5320727\5 254797.000

Agreement. None of the Company, its subsidiaries, any of their affiliates, and any person acting on their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security,
under circumstances that would require registration of any of the Exchanged Shares under the Securities Act or cause this Exchange to be integrated with prior offerings by the Company for purposes of Securities Act or any applicable stockholder
approval provisions, including, without limitation, under the rules and regulations of any exchange or automated quotation system on which any of the securities of the Company are listed or designated. None of the Company, its subsidiaries, their
affiliates and any person acting on their behalf will take any action or steps referred to in the preceding sentence that would require registration of any of the Exchange Shares under the Securities Act or cause the Exchange of the Exchange Shares
to be integrated with other offerings.

     (iv) The Company is current in its filings of all reports, schedules, forms, statements and other documents required to be filed by it with the SEC pursuant to the reporting requirements of the
Securities Exchange Act of 1934, as amended. To the Company’s actual knowledge, upon issuance, the Exchange Shares are eligible for sale by the Holders to the public without registration under the Securities Act.

     (v) The Company confirms that neither it nor any other person acting on its behalf has provided the Holder or their agent or counsel with any information that constitutes or could reasonably be
expected to constitute material, nonpublic information other than with respect to the proposed investment by Ilaro Koskelo (the “New Investment”).  All information relating to the New Investment provided to the Holder by the Company shall
be publicly disclosed at the same time that the transactions contemplated by this Agreement are disclosed pursuant to Section 4(a) hereof. The Company understands and confirms that the Holder will rely on the foregoing representations in effecting
transactions in securities of the Company. Except as disclosed in documents filed by it with the SEC, the Company is not aware of the occurrence of any significant events that would reasonably be likely to have a material negative impact on the
Company’s business and operations or the ability of the Holder to sell any of the Exchange Shares or Warrant Shares.

     (vi) The Company and its counsel have previously or will in connection with the execution of this Agreement, deliver to the transfer agent any required legal opinions or documentation necessary to
effect the delivery of the Exchange Shares to the Holder as required hereby. The Company shall be responsible for the fees of its transfer agent and all DTC fees associated with the issuance of the Exchange Shares hereunder. If, by the third
(3rd) trading day from the date hereof the Company shall fail for any reason or for no reason to issue to the Holder the Exchange Shares by electronic delivery at the applicable balance
account at DTC, and if on or after such Trading Day the holder purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by the holder of such Securities that the holder anticipated receiving
without legend from the Company (a "Buy-In"), then the Company shall, within three (3) Business Days after the holder's request and in the holder's discretion, either (i) pay cash to the
holder in an amount equal to the holder's total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased (the "Buy-In Price"), at which point the
Company's obligation to deliver such unlegended Securities shall terminate, or (ii) promptly honor its obligation to deliver to the

	
3

PHILADELPHIA\5320727\5 254797.000

holder such unlegended Securities as provided above and pay cash to the holder in an amount equal to the excess (if any) of the Buy-In Price over the product of (A) such number of shares of Common Stock, times (B) the Closing Bid
Price (as defined in the Warrants) on the date of exercise.

     (c) Representations, Warranties and Covenants of the Holder. The Holder hereby represents and warrants to the Company that the Holder: (i) is
the sole legal and beneficial owner of the Original Warrant free and clear of any liens, encumbrances, pledges, security interests or other restrictions or claims of third parties, (ii) is an “accredited investor” (as defined in Regulation
D under the Act) and is acquiring the Exchange Shares for its own account and not with a view to any distribution thereof except in compliance with the Securities Act; (iii) is not an "affiliate" of the Company (as defined in Rule 144), (iv) has
made all investigations that it deems necessary or desirable in connection with the transactions contemplated by this Agreement and has had an opportunity to ask questions of and receive answers from the Company, (v) has such knowledge and
experience in financial and business matters as to be capable of evaluating the merits and risks of its investment in the Exchange Shares and the Exchange warrant and (vi) has owned the Original Warrant beneficially and of record since the date of
its original acquisition from the Company. The Holder’s legal residence is as specified in Section 5(b).

     (d) All representations, warranties and agreements of each party hereto shall survive the Closing.

	
4.      		
Covenants	
	 
	 	
(a) Disclosure of Transactions and Other Material Information. The	
	 

Company shall, on or before 8:30 a.m., New York City Time, on the first Business Day after the date of this Agreement, issue a press release (the "Press Release") and Current Report on form 8-K disclosing all material terms of the
transactions contemplated hereby and all material terms of the New Investment. From and after the issuance of the Press Release, the Holder shall not be in possession of any material, nonpublic information received from the Company, any of its
Subsidiaries or any of its respective officers, directors, employees or agents, that is not disclosed in the Press Release. The Company shall not, and shall cause each of its Subsidiaries and each of their respective officers, directors, employees
and agents, not to, provide the Holder with any material, nonpublic information regarding the Company or any of its Subsidiaries from and after the filing of the Press Release without the express written consent of the Holder. The Company shall not
disclose the name of the Holder in any filing, announcement, release or otherwise, unless such disclosure is required by law or regulation.

     (b) Reverse Stock Split. The Company shall not effect a reverse stock split of one or more classes of the Company's Common Stock for at least
90 days following the date hereof.

	
5.      		
Miscellaneous	
	 
	 	
(a) Further Assurances. Each party hereto shall promptly execute and deliver	
	 

	
4

PHILADELPHIA\5320727\5 254797.000

such further agreements and instruments, and take such further actions, as the other party may reasonably request in order to carry out the purpose and intent of this Agreement.

     (b) Notices. All notices, requests, demands and other communications hereunder shall be in writing and shall be deemed given if delivered
personally or by facsimile transmission (with subsequent letter confirmation by mail) or two days after being mailed by certified or registered mail, postage prepaid, return receipt requested, to the parties, their successors in interest or their
assignees at the following addresses, or at such other addresses as the parties may designate by written notice in the manner aforesaid:

	 	
If to the Holder:

	 	
If to the Company:

	 	
With a copy to :

     (c) New Investment; Other Warrant Exchange Agreement.  The closing for the transactions contemplated by this Agreement shall occur
immediately prior to the closing of the New Investment and simultaneously with the closing under the Warrant Exchange Agreement between the Company and
____________________
.  The Company shall close the New Investment immediately after the
closing hereunder.

     (d) Termination of Registration Rights Agreement. All rights of the Holder under the Registration Rights Agreement dated as of May 7, 2007
among, inter alia, the Company and the Holder are hereby terminated and the Holder hereby releases the Company from all claims under such Agreement from the inception of such
Agreement.

     (e) Stockholders’ Meeting. The Company shall use reasonable best efforts to (i) hold a stockholders meeting within 90 days from the date
hereof (the “Stockholder Meeting Deadline”) and (ii) obtain approval of its stockholders of such meeting for the issuance of shares of Common Stock upon exercise of the Exchange Warrant in accordance with the terms of the Exchange Warrant
(“Stockholder Approval”). If despite the Company’s reasonable best efforts, Stockholder Approval is not obtained by the Stockholder Meeting Deadline, the Company shall cause an additional Stockholder Meeting to be held approximately
every six months thereafter until Stockholder Approval is obtained.

     (f) Issuance of Common Stock upon Exercise of Exchange Warrant. Assuming that the Holder has been the sole record and beneficial owner of the
Original Warrant from its issuance until the closing of the transactions contemplated hereby on the Closing Date and is the sole record and beneficial owner of the Exchange Warrant until the applicable date of exercise and there is no intervening
change in applicable law, upon exercise of the Exchange Warrant, the Company will cause the applicable shares of Common Stock to be issued to the Holder without restrictive legend or other impediment to immediate transfer.

	
5

PHILADELPHIA\5320727\5 254797.000

     (g) Governing Law; Jurisdiction; Jury Trial.  All questions concerning the construction, validity, enforcement and interpretation of this
Agreement shall be governed by the internal laws of the State of New York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application
of the laws of any jurisdictions other than the State of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any
dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to
the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process and
consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of
process and notice thereof.  Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES
NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

     (h) Counterparts. This Agreement may be executed in several counterparts, each of which shall be deemed an original, but all of which shall
constitute one and the same instrument.

     (i) Complete Agreement. This Agreement is an integrated agreement containing the entire agreement between the parties hereto with respect to
the subject matter hereof and shall supersede all previous, and all contemporaneous oral or written negotiations, commitments or understandings. 

     (j) Expenses. Except as specifically set forth herein, each party hereto shall bear its own costs and expenses, including, without
limitation, attorneys’ fees, incurred in connection with this Agreement and the transactions contemplated hereby.

	
ENCORIUM GROUP, INC.

By: 
_______________________________________

	
Name: 
_________________________________

Title: 
__________________________________

	
6

PHILADELPHIA\5320727\5 254797.000

HOLDER

By: 
_______________________________________
 Name: 
________________________________
 Title: 
_________________________________

	
7

PHILADELPHIA\5320727\5 254797.000

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00164-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00164-of-00352.parquet"}]]